Senti Bio CEO Timothy Lu to present logic-gated NK cell therapy at AACR meeting
PUBT · 3d ago
Share
Listen to the news
- Senti Biosciences CEO Timothy Lu will present at AACR Annual Meeting 2026 in San Diego on April 17, 2026.
- Talk will cover logic-gated engineered NK cell therapy SENTI-202, including clinical trial results in relapsed or refractory acute myeloid leukemia.
- Educational session scheduled for 3:00-4:30 p.m. PT.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604130900PRIMZONEFULLFEED9688224) on April 13, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved